Michael Wajnrajch

7PUBLICATIONS
30CO-AUTHORS
Primary health careInfant and child healthGene and molecular therapyPharmacogenomicsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 29, 2026
Open-Label 9-Year Follow-Up Extension Phase 2 Study of Once-Weekly Somatrogon in Children With Growth Hormone Deficiency.

|Aug 14, 2025
Persistence with daily growth hormone among children and adolescents with growth hormone deficiency in Japan.

Jane Loftus, Jenifer Wogen, Darrin Benjumea

|Jan 28, 2025
IGF-1 Assessment During Weekly Somatrogon Treatment in Pediatric Patients With GH Deficiency.

Satyaprakash Nayak, Michael P Wajnrajch, Joan Korth-Bradley

|May 08, 2024
Post hoc subgroup analysis of Asian children with paediatric GHD from the global phase 3 efficacy and safety study of once-weekly somatrogon vs. once-daily somatropin.

Roy Gomez, Vaman Khadilkar, Jayashri Shembalkar

|Sep 28, 2023
Real-World Experiences with Taliglucerase Alfa Home Infusions for Patients with Gaucher Disease: A Global Cohort Study.

Shoshana Revel-Vilk, Royston Mansfield, Neta Feder-Krengel

|Feb 01, 2023
Response to Letter to the Editor From Virú-Loza and Chávez-Nomberto: "Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort".

Mohamad Maghnie, Michael B Ranke, Mitchell E Geffner

Pageof 2

Frequent Collaborators

3 joint publications

Roy Gomez

2 joint publications

Mohamad Maghnie

2 joint publications

Michael B Ranke

2 joint publications

Mitchell E Geffner